Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 200 of 504 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/22
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 11/07/18
End: 12/30/19
Due: 12/30/20
Phase: N/A
Priority: Normal
Start: 10/12/23
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 12/30/23
End: 03/01/24
Due: 03/01/25
Phase: N/A
Priority: Normal
Start: 03/31/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/12/18
End: 07/30/20
Due: 07/30/21
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 03/30/27
Due: 03/30/28
Application of Artificial Intelligence Deep Learning Technology in Magnetic Resonance Lumbar Imaging
Phase: N/A
Priority: Normal
Start: 10/08/23
End: 03/08/24
Due: 03/08/25
Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma
Phase: N/A
Priority: Normal
Start: 12/02/20
End: 03/31/23
Due: 03/31/24
Phase: N/A
Priority: Normal
Start: 05/31/23
End: 01/02/27
Due: 01/02/28
Phase: N/A
Priority: Normal
Start: 11/30/16
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 07/14/18
End: 01/31/19
Due: 01/31/20
Phase: N/A
Priority: Normal
Start: 11/28/17
End: 07/31/18
Due: 07/31/19
Phase: N/A
Priority: Normal
Start: 12/01/19
End: 09/30/21
Due: 09/30/22
Phase: N/A
Priority: Normal
Start: 02/28/23
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 09/14/22
End: 06/30/29
Due: 06/30/30
Phase: N/A
Priority: Normal
Start: 05/07/24
End: 08/31/27
Due: 08/31/28
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 02/28/22
Due: 02/28/23
Phase: N/A
Priority: Normal
Start: 07/01/23
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 06/30/18
Due: 06/30/19
Phase: N/A
Priority: Normal
Start: 02/01/21
End: 09/01/22
Due: 09/01/23
Phase: N/A
Priority: Normal
Start: 02/01/21
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 10/01/23
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 05/10/25
End: 09/30/25
Due: 09/30/26